Anti-SIN3B monoclonal antibody

Pre-made anti-SIN3B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SIN3B/SIN3B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2740-Ab-1/ GM-Tg-hg-IP2740-Ab-2Anti-Human SIN3B monoclonal antibodyHuman
GM-Tg-rg-IP2740-Ab-1/ GM-Tg-rg-IP2740-Ab-2Anti-Rat SIN3B monoclonal antibodyRat
GM-Tg-mg-IP2740-Ab-1/ GM-Tg-mg-IP2740-Ab-2Anti-Mouse SIN3B monoclonal antibodyMouse
GM-Tg-cynog-IP2740-Ab-1/ GM-Tg-cynog-IP2740-Ab-2Anti-Cynomolgus/ Rhesus macaque SIN3B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2740-Ab-1/ GM-Tg-felg-IP2740-Ab-2Anti-Feline SIN3B monoclonal antibodyFeline
GM-Tg-cang-IP2740-Ab-1/ GM-Tg-cang-IP2740-Ab-2Anti-Canine SIN3B monoclonal antibodyCanine
GM-Tg-bovg-IP2740-Ab-1/ GM-Tg-bovg-IP2740-Ab-2Anti-Bovine SIN3B monoclonal antibodyBovine
GM-Tg-equg-IP2740-Ab-1/ GM-Tg-equg-IP2740-Ab-2Anti-Equine SIN3B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2740-Ab-1/ GM-Tg-hg-IP2740-Ab-2; GM-Tg-rg-IP2740-Ab-1/ GM-Tg-rg-IP2740-Ab-2;
GM-Tg-mg-IP2740-Ab-1/ GM-Tg-mg-IP2740-Ab-2; GM-Tg-cynog-IP2740-Ab-1/ GM-Tg-cynog-IP2740-Ab-2;
GM-Tg-felg-IP2740-Ab-1/ GM-Tg-felg-IP2740-Ab-2; GM-Tg-cang-IP2740-Ab-1/ GM-Tg-cang-IP2740-Ab-2;
GM-Tg-bovg-IP2740-Ab-1/ GM-Tg-bovg-IP2740-Ab-2; GM-Tg-equg-IP2740-Ab-1/ GM-Tg-equg-IP2740-Ab-2
Products NameAnti-SIN3B monoclonal antibody
Formatmab
Target NameSIN3B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SIN3B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2740-Ag-1Recombinant multi-species SIN3B protein
    ORF Viral VectorpGMLPm000523mouse Sin3b Lentivirus plasmid
    ORF Viral VectorvGMLPm000523mouse Sin3b Lentivirus particle


    Target information

    Target IDGM-IP2740
    Target NameSIN3B
    Gene ID23309,20467,683381,718813,610198,101080768,520505,100069936
    Gene Symbol and Synonyms2810430C10Rik,SIN3B
    Uniprot AccessionO75182
    Uniprot Entry NameSIN3B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000127511
    Target ClassificationN/A

    The target: SIN3B, gene name: SIN3B, also named as . Predicted to enable transcription corepressor activity. Predicted to be involved in histone deacetylation; negative regulation of transcription by RNA polymerase II; and striated muscle tissue development. Predicted to be located in nucleus. Predicted to be part of Sin3 complex. Predicted to be active in chromatin. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.